| American Shared Hospital Services Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/14 |
07:00 |
| Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab |
Globe Newswire |
05/14 |
07:00 |
| Talisker Announces 2026 Mineral Resource Statement for the Bralorne Gold Project |
Globe Newswire |
05/14 |
07:00 |
| Pelthos Therapeutics Announces First Quarter 2026 Financial Results |
Globe Newswire |
05/14 |
07:00 |
| Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance |
Globe Newswire |
05/14 |
07:00 |
| POET Technologies and Lumilens Advance Wafer-Level Photonic Integration for Next-Generation AI Optical Networks |
Globe Newswire |
05/14 |
07:00 |
| EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data |
Globe Newswire |
05/14 |
07:00 |
| Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting |
Globe Newswire |
05/14 |
07:00 |
| PyroGenesis Announces a Binding Signed Contract to Acquire its Turcot Manufacturing Facility |
Globe Newswire |
05/14 |
07:00 |
| Bitdeer Reports Unaudited Financial Results for the First Quarter of 2026 |
Globe Newswire |
05/14 |
07:00 |
| Legence Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/14 |
07:00 |
| Barrick Announces Election of Directors |
Globe Newswire |
05/14 |
07:00 |
| Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions |
Globe Newswire |
05/14 |
07:00 |
| Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026 |
Globe Newswire |
05/14 |
07:00 |
| Bitcoin.com Partners with Dinari to Bring Tokenized U.S. Equities to a Global Audience |
Globe Newswire |
05/14 |
07:00 |
| Deep Isolation Nuclear, Inc. Reports Operational and Financial Results for the First Quarter of 2026 |
Globe Newswire |
05/14 |
07:00 |
| Aebi Schmidt Group reports 9% growth in Order Intake, continued increase in Order Backlog of 23%, strong underlying growth and profitability, and confirms full-year 2026 guidance |
Globe Newswire |
05/14 |
07:00 |
| GH Research Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/14 |
07:00 |
| CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder |
Globe Newswire |
05/14 |
07:00 |
| Boralex reports higher operating income and the addition of new growth projects in the first quarter of 2026 |
Globe Newswire |
05/14 |
07:00 |
| XORTX Announces US$5 Million Public Offering |
Globe Newswire |
05/14 |
07:00 |
| Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones |
Globe Newswire |
05/14 |
07:00 |
| Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates |
Globe Newswire |
05/14 |
07:00 |
| 4basebio Announces Appointment of Chief Financial Officer and Board Changes |
Globe Newswire |
05/14 |
07:00 |
| Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease |
Globe Newswire |
05/14 |
06:59 |
